Delivery Order SPE2DB20D3103-SPE2DB24FQ0Q6
Award Date
8/27/24
Potential Completion Date
8/28/24
Potential Value
$30K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,376.42 firm fixed-price delivery order is for the supply of 88 ml vials of 50 mg/ml valganciclovir HCl, a medication used in the treatment of viral infections. The contract has an ultimate completion date of March 7, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
This is a federal delivery order contract (SPE2DB22D1106) awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $15,811.34, is for the delivery of 88 mL of valganciclovir hydrochloride 50 mg/mL medication. It has a firm fixed price pricing type and a period of performance through November 7, 2024. The award is associated with a larger Indefinite Delivery Contract (IDC) valued...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Valganciclovir 450 mg tablets. The fixed-price contract has a ceiling value of $1,559.32 and a completion date of February 9, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC provides a...
This federal contract award, valued at $3,507.63, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 60 units of 450 mg Valganciclovir tablets, a medication used for the treatment of cytomegalovirus (CMV) infections. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of December 31, 2024. AmerisourceBergen holds a...
The federal contract award is for the delivery of 60 tablets of 450 mg Valganciclovir, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on June 6, 2024 with a ceiling value of $1,574.11 and a completion date of June 7, 2024. This contract is a delivery order against AmerisourceBergen's Indefinite Delivery Contract (IDC) with the...
This federal contract award, valued at $4,629.32, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Valganciclovir 450 mg tablets, a medication used in the treatment of cytomegalovirus infections. The contract is a Firm Fixed Price Delivery Order, with a completion date of January 21, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract...
This federal contract award is for the delivery of 60 tablets of 450 mg Valganciclovir, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $1,186.10 firm fixed-price delivery order was issued to the prime contractor, Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of August 9, 2024 and was awarded on August 8, 2024. This delivery order appears to be part of a larger Indefinite...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation, is a firm fixed price delivery order with a ceiling value of $1,111.53 for the supply of valganciclovir hydrochloride 50 mg/mL oral solution. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the U.S. Department of Defense, to support military treatment programs and facilities. The delivery...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 450 mg valganciclovir tablets, a medication used to treat cytomegalovirus infections. The contract has a ceiling value of $5,341.60 and a period of performance through June 11, 2025. It is a firm-fixed-price contract with no set-aside designation, indicating open...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 60 tablets of 450 mg Valganciclovir, a prescription medication. The firm fixed-price delivery order has a ceiling value of $1,633.96 and a completion date of May 30, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...